Insider Transactions in Q4 2022 at Harrow Health, Inc. (HROW)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2022
|
R. Lawrence Van Horn Director |
BUY
Open market or private purchase
|
Direct |
1,860
+50.0%
|
$24,180
$13.42 P/Share
|
|
Dec 22
2022
|
Andrew R. Boll CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,500
+0.97%
|
$32,500
$13.54 P/Share
|
|
Dec 22
2022
|
Mark L Baum CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
25,000
+1.72%
|
$325,000
$13.39 P/Share
|
|
Dec 21
2022
|
Martin A. Makary Director |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$325,000
$13.37 P/Share
|
|
Dec 14
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
431,183
+9.4%
|
$4,311,830
$10.52 P/Share
|